Clicca in qualsiasi punto o premi ESC per chiudere il video

PTM Consulting
A New Approach to Risk Management

For over 20 years, PTM Consulting has been a scientific and methodological reference point in the Life Sciences sector, providing comprehensive support for:

Quality Management

Drug development using QbD

Quality Risk
Management

Combination Product development

Technology transfer

The company is known for its ability to analyze project issues through a new lens, combining proven tools with innovative Knowledge Management methods.

PTM’s philosophy transforms Quality Risk Management from a simple operational tool into a strategic lever to support corporate decision-making.

This vision results in a renewed approach to processes and risks that goes far beyond merely providing regulatory compliance consulting or just another software tool.

 

PTM’s consolidated experience in Quality by Design principles ensures the integration of quality from the early stages of product or process development, speeding up technology transfer and preserving critical information.

 

This approach ensures a product life cycle that is optimized, compliant with regulations, and -most
importantly- focused on continuous improvement.

PTM Consulting Services

We offer advanced solutions that enable our clients to extract meaningful insights from their data, optimize quality, drive process development, and build a lasting, reusable asset that increases business value over time.

Integrated quality
risk management

Quality by design

Technology transfer

Quality and GMP 
support

Data integrity & computer System validation

Medical device & combination

PTM Consulting Partnerships

PTM Consulting actively collaborates with universities, trade associations, and national and international certification authorities. These partnerships allow the company to develop innovative and forward-thinking methodologies, always aligned with industry standards.

 

It also designs specialized training programs that reflect the evolving technical and regulatory landscape of the Life Sciences sector, equipping clients with the critical internal skills they need to respond quickly to regulatory changes.

Cymapp®: PTM Consulting’s Vision in a Software Solution

Choosing Cymapp® means adopting not just a software tool, but a new, innovative vision of Risk Management.

Cymapp® is the tangible result of 20 years of expertise from a multidisciplinary team of experts in Quality Assurance, Quality Risk Management, Quality by Design, pharmaceuticals, engineering, and ICT.

Every feature is based on the real-world experience of professionals who have personally faced the day-to-day challenges of companies in the medical and pharmaceutical industries.

Cymapp® goes beyond the traditional linear and regulatory-focused approach to Risk Management. It introduces a model that, through mapping, not only traces and visualizes process sequences but also shows the cross-connections between apparentrly unrelated variables.

Unlike generic software solutions, developed by IT companies and later adapted to medical or pharmaceutical contexts, Cymapp® represents a paradigm shift. It was born from two decades of consulting experience addressing real problems and opportunities in the pharmaceutical industry. It enables companies to build a growing knowledge base that becomes increasingly accurate and predictive over time.

Paolo Mazzoni

Fondatore and CEO of PTM Consulting

  • Paolo Mazzoni began his career at Barilla, focusing primarily on packaging development. As New Product Introduction Manager at GSK, he turned his focus to the Life Sciences sector, managing both the Packaging Unit and Device division.
  • He later served as Director of Medical Customer Assurance at Flextronics, overseeing the development and production of medical devices—especially in the US and Asia.
  • In 2002, leveraging his expertise in Risk Management applied the entire product life cycle, he founded PTM Consulting. Under his leadership, the company has grown into a key industry reference point. Today, Paolo serves as both CEO and CTO (R&D).